Sterility assurance in cell therapy products

In this webinar, Dr Tim Sandle considers sterility assurance principles, rapid microbiological methods, environmental monitoring and much more.



Cellular therapy products represent a new wave in pharmaceuticals and include cellular immunotherapies, cancer vaccines and other types of both autologous and allogeneic cells for certain therapeutic indication. While the products are novel, sterility assurance concerns remain fundamental.


Topic areas we cover include:
  • Sterility assurance principles
  • Sterility testing
  • Rapid microbiological methods
  • Environmental monitoring
  • Facility, equipment, raw materials, test system, and personnel
  • Control of the collection, processing, packaging, and distribution of cell products

Register for this on demand webinar

About the speaker:



Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.

Contact us

Call us on either number below

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.